Morgan Stanley analyst Michael Ulz maintained a Buy rating on Sarepta Therapeutics (SRPT – Research Report) today and set a price target of $182.00. The company’s shares closed yesterday at ...

Arcturus Therapeutics (ARCT) announced that the FDA has granted fast track designation for the self-amplifying mRNA vaccine candidate, ARCT-2304, designed for active immunization to protect ...

Dr. Nancy Messier and Dr. Thierry Abribat join Find Therapeutics to support its mission and growth. MONTRÉAL, April 10, 2025 /PRNewswire/ - Find Therapeutics Inc., a biopharmaceutical company ...

CAMBRIDGE, Mass., April 10, 2025 /PRNewswire/ -- Pykus Therapeutics, Inc. ("Pykus" or the "Company") announced today that it has completed enrollment of its pilot study (PYK-2101-RD001 ...

Dr. Nancy Messier and Dr. Thierry Abribat join Find Therapeutics to support its mission and growth. MONTRÉAL, April 10, 2025 /CNW/ - Find Therapeutics Inc., a biopharmaceutical company dedicated to ...

Summit Therapeutics Inc., a biopharmaceutical company, focuses on discovery, development, and commercialization of patient, physician, caregiver, and societal friendly medicinal therapies in the ...

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...